(CHROMagar Orientation + ESBL supplement)

Failure to rapidly detect antibiotic resistence in gram-negative bacteria has contributed to their uncontrolled spread, and on occasions to therapeutic failures. CHROMagar has introduced a set of selective supplements specially designed for screening gram-negative bacteria which express different kinds of used antibiotics susceptibility.

CHROMagar™ ESBL Supplement added to CHROMagar™ Orientation contributes to the rapid screening of Gram-negative ESBL-producing bacteria.

CHROMagar™ ESBL Supplement allows the detection of ESBL-producing bacteria while inhibiting the growth of other bacteria, including most of those carrying ampC type resistance. This is an important feature because intrinsic ampC resistance has less epidemic relevance, but often leads to ESBL false positive reading in the classical testing methods.